CHINA AND THE PRODUCTION OF MEDICINES

China-Brazil Cooperation in one of the fastest-growing industries in 2020

You are probably aware that distrust of vaccines produced in partnership with China in Brazil is high. But what little is said is that China is the largest producer of inputs in biotechnology in the world.

Learn more about China’s impact on global drug production!

WHAT YOU WILL FIND BY ACCESSING OUR MATERIAL
In this material, you will have access to the most recent data on the situation of medicines in China, Brazil, and the world, including:
  • Pharmaceutical Industry in China
  • Vaccine Imports in Brazil in 2020
  • Distribution of vaccines around the world
  • Importance of China in world production
  • Worldwide Import Numbers of Major Pharmaceutical Assets
  • Export data
  • And much more!

Informe seus dados

Para baixar o conteúdo gratuitamente preencha o formulário a seguir

50% of people would not get a vaccine from China.

23% of people would get a US vaccine.

35% of pharmaceutical inputs in Brazil come from China.

Would you get a vaccine from China?

In a recent survey by Datafolha, 50% of respondents said they would not take a vaccine from China even if it had been approved, against only 23% in the United States, 26% in England, and 36% in Russia.

Brazil, like other countries, already imports a huge amount of medicines and pharmaceutical inputs from the Asian country. The truth is that most of the medicines produced in Brazil today contain inputs from China.

The year 2020 was marked by the COVID-19 pandemic and this had a strong impact on the numbers of the pharmaceutical industry worldwide, including Brazil-China relations.

Inova China is the hub solely dedicated to building bridges of innovation between China and Brazil. We offer the tools and insights for a successful strategy.

To learn more, please contact us!

Somos o hub especializado no desenvolvimento de oportunidades inovadoras entre o Brasil e na China.

Siga-nos nas redes sociais:

Sobre

Quem somos
Trabalhe conosco

Conteúdos

Infográficos
Relatórios
Blog

Conteúdos

Capacitação
Soluções corporativas
Conteúdos
Apoio a investimentos
Missões Tech China

Contato

Quem somos
Trabalhe conosco

Newsletter